Back

Mineralocorticoid receptor antagonists after acute myocardial infarction in patients with mild to moderately reduced ejection fraction

22 May 2023 (15:24 - 17:00)
Organised by: Logo
Congress Presentation Part of: ePosters in CAD - CCS - ACS 5 Treatment HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Catarina Carvalho

ULSAM - Hospital de Santa Luzia, Viana do Castelo (Portugal)

4 More presentations in this session

Presentation thumbnail
Risk assessment and clinical outcome for CABG in patients with coronary artery disease and severely impaired left ventricular ejection fraction
Professor F. Schoenrath (Berlin, DE)
Abstract Slides
Presentation thumbnail
Predictive value of NT-proBNP on long term MACE in STEMI patients
Associate Professor A. Bakalli (Pristina, XK)
Abstract Slides
Presentation thumbnail
Gender differences in in-hospital outcome of patients with acute myocardial infarction undergoing percutaneous coronary intervention in Kosovo
Professor S. Elezi (Pristina, XK) Professor G. Bajraktari (Pristina, XK)
Abstract Slides
Presentation thumbnail
Predictors of in-hospital mortality of patients with acute myocardial infarction in Kosovo
Professor G. Bajraktari (Pristina, XK)
Abstract Slides

Access the full session

Session thumbnail
ePosters in CAD - CCS - ACS 5

The Event

Event poster

Heart Failure 2023

22 May 2023 15:24 CET
You may be interested in
thumbnail
Congress Presentation
The mineralocorticoid receptor antagonists in heart failure with preserved ejection fraction
29 June 2021
thumbnail
Congress Presentation
Trajectories and determinants of myocardial work indices in patients with acute myocardial infarction after primary percutaneous coronary intervention
13 December 2024
thumbnail
Congress Presentation
Mid-range ejection fraction after acute myocardial infarction
29 June 2021
thumbnail
Congress Presentation
Is there still a role for neurohormonal therapy in patients with STEMI and mildly reduced ejection
22 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources